Full Schedule

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Chair: Fernanda Lemos, RN – member of organization comitee - IMS

Chair: Gabriela Rocco de Sá, RN: Post-graduation in public health, clinical oncology and health management. 15 years of experience in hematology oncology and bone marrow transplantation, (she/her/hers) – Hospital Israelita Albert Einstein

Chair: Tracy King, PhD, MSc, RN – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Anant Madabhushi, PhD (he/him/his) – Emory University

Co-Chair: Tiffany A. Richards, PhD, ANP-BC AOCNP (she/her/hers) – MD Anderson Cancer Center

Co-Chair: Tracy King, PhD, MSc, RN – Institute of Haematology, Royal Prince Alfred Hospital

Speaker: Jens Hillengass, MD, PhD (he/him/his) – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Speaker: Orla McCourt, PhD – University College London NHS Foundation Trust

Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital

Speaker: Danielle L. Roberts, PA-C (she/her/hers) – Winship Cancer Institute, Emory University

Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA

Co-Chair: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Speaker: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Speaker: Madhav V. Dhodapkar, MD, (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Speaker: Vincent Rajkumar, MD – Mayo Clinic

Speaker: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain

Panelist: Elena Zamagni, Sr., MD, PhD (she/her/hers) – European Myeloma Network, Italy

Panelist: Irene Ghobrial, MD (she/her/hers) – Dana-Farber Cancer Institute, Boston, MA, USA

Panelist: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland

Panelist: Madhav V. Dhodapkar, MD, (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA

Panelist: Vincent Rajkumar, MD – Mayo Clinic

Co-Chair: Charise Gleason, NP-C – Winship Cancer Institute of Emory University

Co-Chair: Orla McCourt, PhD – University College London NHS Foundation Trust

Speaker: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil

Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK

Speaker: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Speaker: Rebecca Lu, MS, FNP-C* – The University of Texas MD Anderson Cancer Center

Co-Chair: Natalie Callander, MD – University of Wisconsin

Co-Chair: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center

Speaker: Verónica González-Calle, MD, PhD (she/her/hers) – Department of Hematology, University Hospital of Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain

Speaker: Jill CORRE, PharmD, PhD (she/her/hers) – Institut Universitaire du Cancer de Toulouse-Oncopole

Speaker: Meletios A. Dimopoulos, MD – National and Kapodistrian University of Athens

Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine

Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Dana-Farber Cancer Institute, Boston, MA, USA

Co-Chair: Niccolo Bolli, MD, PhD – University of Milan

Co-Chair: Michel Delforge, MD/Phd (he/him/his) – University of Leuven, Leuven, Belgium

Speaker: Chaitanya R. Acharya, PhD (he/him/his) – Multiple Myeloma Research Foundation

Speaker: Andrew McPherson, PhD – Memorial Sloan Kettering Cancer Center

Speaker: Ariosto Siqueira Silva, PhD – H. Lee Moffitt Cancer Center and Research Institute

Speaker: Tina Bagratuni, PhD (she/her/hers) – National and Kapodistrian University of Athens

Speaker: Chaitanya R. Acharya, PhD (he/him/his) – Multiple Myeloma Research Foundation

Co-Chair: Monica Morris, MSc, RN – Myeloma UK

Co-Chair: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Speaker: Vincent Rajkumar, MD – Mayo Clinic

Speaker: Sara A. Scott, PharmD, BCOP – Winship Cancer Institute, Emory University

Speaker: Tracy King, PhD, MSc, RN – Institute of Haematology, Royal Prince Alfred Hospital

Panelist: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health

Panelist: Mary Steinbach, DNPli APRN – Huntsman Cancer Institute/University of Utah

Panelist: Jacqui Jagger, RN, BA(Hons), MN(NP) – CCLHD

Panelist: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Speaker: Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO (she/her/hers) – Cleveland Clinic

Chair: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Joseph Mikhael, MD – Translational Genomics Research Institute (TGen), City of Hope Cancer Center

Speaker: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Speaker: Roberto Mina, MD – European Myeloma Network, Italy

Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Speaker: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Panelist: Roberto Mina, MD – European Myeloma Network, Italy

Panelist: Fredrik Schjesvold, MD, PhD – Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo

Panelist: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA

Panelist: Luciano J. Costa, MD, PhD – University of Alabama at Birmingham, Birmingham, AL, USA

Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Co-Chair: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Speaker: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Speaker: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Speaker: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Speaker: Salomon Manier, MD, PhD – Lille University Hospital

Speaker: Philippe Moreau, MD, PhD (he/him/his) – University Hospital Hôtel-Dieu, Nantes, France

Panelist: Hartmut Goldschmidt, MD (he/him/his) – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)

Panelist: Francesca Gay, MD – Division of Hematology 1, Clinical trial unit AOU città della salute e della scienza, University of Torino

Panelist: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine

Panelist: Nizar J. Bahlis, MD – Arnie Charbonneau Cancer Institute - University of Calgary

Panelist: Dorotea Fantl, MD – Hospital Italiano de Buenos Aires, Argentina.

Panelist: Salomon Manier, MD, PhD – Lille University Hospital

Co-Chair: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE

Co-Chair: Brian GM Durie – Cedars-SInai Cancer Center, Los Angeles CA 90046

Speaker: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Panelist: Ola Landgren, MD, PhD (he/him/his) – University of Miami, Sylvester Comprehensive Cancer Center

Panelist: Shaji K. Kumar, MD – Mayo Clinic, Rochester, MN, US

Panelist: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School

Panelist: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra

Discussant: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Poster Presenter: Diana Basali, MD – Cleveland Clinic

Discussant: Rafat Abonour, Professor – Indiana University School of Medicine

Poster Presenter: Ulrike Dapunt, MD – Internal Medicine V, GMMG-Study Group at University Hospital Heidelberg, Heidelberg, Germany

Discussant: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Poster Presenter: Rahul Banerjee, MD (he/him/his) – Fred Hutchinson Cancer Center

Discussant: Rafat Abonour, Professor – Indiana University School of Medicine

Poster Presenter: Ulrike Dapunt, MD – Internal Medicine V, GMMG-Study Group at University Hospital Heidelberg, Heidelberg, Germany

Discussant: P.Joy Ho, MBBS DPhil FRACP FRCPA – Institute of Haematology, Royal Prince Alfred Hospital

Poster Presenter: Ioannis Ntanasis-Stathopoulos, MD, MSc, PhD – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece

Discussant: Diana Cirstea

Poster Presenter: Tommer Mark

Poster Presenter: Salomon Manier, MD, PhD – Lille University Hospital

Discussant: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Discussant: Rafat Abonour, Professor – Indiana University School of Medicine

Poster Presenter: Patrick Born (he/him/his) – University Leipzig Medical Center, Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, Leipzig, Germany

Discussant: Andrew J. Yee, MD – Massachusetts General Hospital Cancer Center

Poster Presenter: Timothy M. Schmidt, MD (he/him/his) – University of Wisconsin

Discussant: Diana Cirstea

Poster Presenter: María-Victoria Mateos, MD, PhD – University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain